Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1073–1082. doi: 10.1097/MEG.0000000000000152

Table 1. Demographic and clinical characteristics of a U.S. chronic HCV population in a commercial insurance database, 2006-2010.

2006 2007 2008 2009 2010 Weighted Average
Enrollees, n (71,584 individuals, 106,283 cross-sections)
16,216 16,235 25,380 24,683 23,769 N=106,283

Sociodemographics, %

Age in years, mean 49.7 50.4 51.2 51.8 52.4 51.2
 (±SD) (7.3) (7.3) (7.5) (7.5) (7.6) (7.5)
Gender, male 61.5 61.4 62.1 62.6 62.8 62.2

Health plan type
 Comprehensive 4.9 2.0 2.7 2.3 2.8 2.9
 HMO 14.7 15.1 23.1 18.5 16.7 18.1
 POS 10.6 11.0 9.3 8.4 8.0 9.3
 PPO 67.3 69.4 62.1 67.7 64.0 65.7

Region
 Northeast 8.8 7.5 18.6 12.5 16.2 13.5
 North Central 19.8 18.7 15.5 16.3 15.6 16.8
 South 51.5 52.5 48.1 50.6 42.6 48.6
 West 19.5 20.9 17.6 20.5 24.8 20.7

Comorbidities, %

Metabolic
 Hypertension 32.0 34.8 37.5 43.2 44.7 39.2
 Lipid metabolism disorders 19.2 20.8 22.4 26.7 27.5 23.8
 Type II diabetes 16.4 17.3 18.7 20.0 20.3 18.8
 Clinically-defined obesity 2.1 2.8 3.2 5.9 6.5 4.3

Psychiatric
 Depression 12.2 13.0 12.6 16.2 16.7 14.4
 Drug abuse/dependence 3.3 3.1 3.7 5.3 5.6 4.3
 Alcohol abuse/dependence 2.9 3.1 3.8 5.3 5.8 4.3
 Bipolar disorders 2.2 2.4 2.5 2.9 2.9 2.6

Hepatic
 Compensated cirrhosis 18.0 19.9 20.2 23.6 26.5 22.0
 Advanced liver disease 9.9 10.7 11.1 13.8 15.5 12.5
 NAFLD 5.0 5.7 6.5 8.1 8.8 7.0
 Alcoholic liver disease 3.9 4.0 4.2 5.0 5.9 4.7
 Liver transplant 3.2 3.4 3.7 4.3 4.7 3.9
 Viral hepatitis B 3.6 3.5 4.0 3.5 3.6 3.7
 Hepatocellular carcinoma 1.8 2.3 3.1 3.3 4.0 3.0

Other
 COPD or asthma 8.0 8.8 9.4 11.1 11.6 10.0
 Rheumatoid arthritis 3.1 3.0 3.1 3.4 3.4 3.2
 HIV/AIDS 1.9 2.2 3.0 3.2 3.2 2.8

Abbreviations: SD, standard deviation; chronic HCV, chronic Hepatitis C virus infection; HMO, Health Maintenance Organization; POS, Point of Service; PPO, Preferred Provider Organization; NAFLD: non-alcoholic fatty liver disease; COPD, chronic obstructive pulmonary disease; HIV/AIDS: human immunodeficiency virus/acquired immunodeficiency syndrome